LT - (+)-2-[1-(3-etoksi-4-metoksi-fenil)-2-metansulfonil-etil]-4- acetilaminoizoindolin-1,3-diono preparatai
EN - FORMULATIONS OF (+)-2-[1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL]-4-ACETYL AMINOISOINDOLINE-1,3-DIONE
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 9/00 |
(2006.01) |
|
|
A61K 9/28 |
(2006.01) |
|
|
A61K 31/4035 |
(2006.01) |
|
|
A61P 29/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3756650 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
20172615.5 |
|
Date of filing the European patent application |
2012-12-26 |
| (97) |
Date of publication of the European application |
2020-12-30 |
| (45) |
Date of publication and mention of the grant of the patent |
2025-08-20
|
| (46) |
Date of publication of the claims translation |
2025-11-10
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
201161580626 P |
2011-12-27
|
US |
Inventors
| (72) |
BHAT, Sreenivas S. , US
KELLY, Michael T. , US
|
Grantee
| (73) |
Amgen (Europe) GmbH ,
Floor 6-8
Suurstoffi 22, 6343 Risch-Rotkreuz,
CH
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
(+)-2-[1-(3-etoksi-4-metoksi-fenil)-2-metansulfonil-etil]-4- acetilaminoizoindolin-1,3-diono preparatai |
| |
FORMULATIONS OF (+)-2-[1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL]-4-ACETYL AMINOISOINDOLINE-1,3-DIONE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-11-19 |
14 |
289.00
EUR
|
Next renewal fee
|
2026-12-26 |
